Japan Stops Use of Pfizer, Sanofi Vaccines on Four Deaths
This article is for subscribers only.
Japan’s health ministry suspended the use of pediatric vaccines made by Pfizer Inc. and Sanofi-Aventis SA after reports of four deaths following immunizations.
The use of Pfizer’s Prevenar, to protect children against meningitis and pneumonia, and Sanofi’s ActHIB, to fight Haemophilus influenzae type b, will be suspended until at least tomorrow, when a safety panel will meet to discuss the cause of the deaths, the ministry said in a March 4 website posting.